Could a new score spare men from unnecessary prostate biopsies?
Diagnosis
Not yet recruiting
This study is testing whether a new scoring system, called the Fusion CEMEP score, can safely guide prostate biopsy decisions. The goal is to see if men with suspected prostate cancer can skip the extra systematic biopsies and only have targeted biopsies based on MRI findings. Th…
Sponsor: Marcelo Ruben Oliva • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC